Basics of the virology of HIV-1 and its replication

被引:89
作者
Sierra, S
Kupfer, B
Kaiser, R
机构
[1] Univ Cologne, Inst Virol, D-50935 Cologne, Germany
[2] Univ Bonn, Inst Med Microbiol & Immunol, D-53105 Bonn, Germany
关键词
HIV-1; replication cycle; viral persistence; antiretroviral therapy; immune response; receptors;
D O I
10.1016/j.jcv.2005.09.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus is undoubtedly the causative agent of AIDS. The understanding of HIV-1 pathogenesis is essentiell to develop and maintain antiretroviral treatment and vaccination. Since the first isolation of HIV-1 in cell culture, thousands Of publications dealing with HIV and/or AIDS per year were released. In this review we give a basic overview of the virology of HIV-1 including the functions of the different HIV-1 proteins required for effective viral replication. Moreover, we summarize the interactive processes between HIV-1 and its target cells. Finally, the HIV-1 specific immune response and the current status of antiretroviral therapy are briefly described in this review. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 185 条
[81]  
KOHISTAEDT LA, 1992, SCIENCE, V256, P1783
[82]   THE P6(GAG) DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS SUFFICIENT FOR THE INCORPORATION OF VPR INTO HETEROLOGOUS VIRAL PARTICLES [J].
KONDO, E ;
MAMMANO, F ;
COHEN, EA ;
GOTTLINGER, HG .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2759-2764
[83]   PROGNOSTIC VALUE OF HIV-1 SYNCYTIUM-INDUCING PHENOTYPE FOR RATE OF CD4+ CELL DEPLETION AND PROGRESSION TO AIDS [J].
KOOT, M ;
KEET, IPM ;
VOS, AHV ;
DEGOEDE, REY ;
ROOS, MTL ;
COUTINHO, RA ;
MIEDEMA, F ;
SCHELLEKENS, PTA ;
TERSMETTE, M .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :681-688
[84]   A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation [J].
Kostrikis, LG ;
Huang, YX ;
Moore, JP ;
Wolinsky, SM ;
Zhang, LQ ;
Guo, Y ;
Deutsch, L ;
Phair, J ;
Neumann, AU ;
Ho, DD .
NATURE MEDICINE, 1998, 4 (03) :350-353
[85]   Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: Lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement [J].
Kostrikis, LG ;
Cao, YZ ;
Ngai, H ;
Moore, JP ;
Ho, DD .
JOURNAL OF VIROLOGY, 1996, 70 (01) :445-458
[86]  
Kupfer B, 1998, J MED VIROL, V56, P259, DOI 10.1002/(SICI)1096-9071(199811)56:3<259::AID-JMV14>3.3.CO
[87]  
2-#
[88]   Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J].
Kwong, PD ;
Wyatt, R ;
Robinson, J ;
Sweet, RW ;
Sodroski, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6686) :648-659
[89]   Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro [J].
Lanman, J ;
Sexton, J ;
Sakalian, M ;
Prevelige, PE .
JOURNAL OF VIROLOGY, 2002, 76 (14) :6900-6908
[90]   DELINEATION OF A REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GLYCOPROTEIN CRITICAL FOR INTERACTION WITH THE CD4 RECEPTOR [J].
LASKY, LA ;
NAKAMURA, G ;
SMITH, DH ;
FENNIE, C ;
SHIMASAKI, C ;
PATZER, E ;
BERMAN, P ;
GREGORY, T ;
CAPON, DJ .
CELL, 1987, 50 (06) :975-985